Page results
-
What does the staff experience team do? The Staff Experience team brings many amazing initiatives to our hardworking teams across UCLH. We’ve delivered the Be Well programme to support health…
-
This page has been written for women and families who use the UCLH Small Baby Clinic.
-
UCLH has opened a new clinic for neurology patients with ‘long Covid’ at the National Hospital for Neurology and Neurosurgery (NHNN) with funding from the National Brain Appeal. The…
-
The UCLH Ambulatory Care (AC) service delivers a range of treatments which have historically been administered within the inpatient setting. Eligible patients receive their care in the AC area…
-
November is men’s health month (Movember), we are hosting our first public Live Q&A event via MS Teams.
-
The support and information specialists were shortlisted for a self-care innovation award. The award recognises the achievements of the team in developing and delivering a package of support for…
-
What is malaria? Malaria is an important cause of fever in travellers returning from Africa, Asia and South America. It is an infection caused by the malaria parasite (Plasmodium), which is…
-
The Inherited White Matter Disorders (IWMD) Diagnostic and Management Service is a formally commissioned highly specialised service. There are seven centres across England. There are three…
File results
-
FOI/2023/0005 - Endoscopy numbers - inflammatory bowel disease
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab